The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$94.50Fair value$142.21Bull$263.49
FairClose
52-week traded range
52W low $86.1252W high $127.16
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Clorox closed at $87.76, 38.3% below the consensus fair value of $142.21 drawn from 7 valuation models.
Financial DNA score 59/100 — Good. P/E of 13.5x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$121.59
+38.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
P/E Fair Value
$130.40
+48.6%
EPS × 20x (sector P/E)
EPS=6.52, Sector P/E=20x
Peter Lynch (PEG)
$124.79
+42.2%
EPS × Growth% (PEG = 1 is fair)
EPS=6.52, g=19.1%
EV/EBITDA
$169.27
+92.9%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=1.3B
Dividend Discount (DDM)
$263.49
+200.2%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=4.88, r=10%, g=8%
Reverse DCF
$87.76
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 1.8% | Historical: 19.1%
Margin of Safety
$94.50
+7.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=126, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.